Oncology companies

Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis.

SillaJen is a biotechnology company focused on engineering and developing oncolytic virus immunotherapeutics.

ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer.

Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.

Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.

Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.

Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on developing oncology therapies.

ORIC is a pharmaceutical company dedicated to discovering and developing therapies towards overcoming resistance in cancer.

Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.

MEDSIR (Medica Scientia Innovation Research) is an international research organization specializing in clinical oncology.